Microversal LLC

Microversal LLC is a biotechnology company focused on developing oral microbiome treatments to prevent dental disease. The company has created a proprietary technology, the Oral Microbiome Transplant (OMT), which involves collecting, studying, and curating beneficial bacteria from donors with naturally perfect oral health. By using an artificial mouth model for research and safety testing, the company aims to introduce these healthy microbes into the mouths of patients, displacing harmful bacteria that contribute to cavities and other dental issues. This research is supported by a team of dental and microbiome experts, including PhDs and researchers with extensive experience in the field.

The company's mission is to provide an accessible and effective preventative solution for oral health, specifically targeting populations with limited access to dental care. By replacing pathogenic bacteria with a protective layer of healthy microbes, Microversal LLC seeks to stop dental disease before it begins. The technology has been featured in dental health publications and is currently in the process of raising funds for human clinical trials following the completion of safety-focused animal studies. Microversal LLC intends to make this therapy widely available through clinical channels to improve long-term dental health outcomes.